News Summary

Femtech Canada has announced the launch of its first commercialization program, the Women’s Health Medical Pathway (wHealth MedPath), aimed at supporting Canadian women’s health startups. The program, created in partnership with Hamilton’s Innovation Factory and partly funded by the National Research Council of Canada Industrial Research Assistance Program, provides up to $20,000 in commercialization assessment and assistance. It offers startups a two-level application process involving product market assessments by physician networks and connections with contract organizations for commercialization projects. Femtech Canada, founded by Hyivy Health’s Rachel Bartholemew, aims to position Canada as a global leader in the femtech sector, boasting one of the world’s largest ecosystems with 170 companies and over $250 million in investments.